Role of HLA allele polymorphism in chronic hepatitis B virus infection and HBV vaccine sensitivity in patients from eastern Turkey

Biochemical Genetics

Volumn 49, Issue 3-4, 2011, Pages 258-269

  Albayrak, Ayse ^a   Ertek, Mustafa ^b   Tasyaran, Mehmet Akin ^c   Pirim, Ibrahim ^d  

^a Erzurum Region Education and Research Hospital   (Turkey)

^b Refik Saydam National Public Health Agency   (Turkey)

^c Ataturk Education and Training Hospital   (Turkey)

^d ATATURK UNIVERSITY   (Turkey)

Author keywords

Chronic hepatitis B; HBV vaccination; Hepatitis B virus; HLA allele

Indexed keywords

HEPATITIS B VACCINE; HLA A11 ANTIGEN; HLA A24 ANTIGEN; HLA ANTIGEN; HLA B35 ANTIGEN; HLA CW4 ANTIGEN; HLA CW6 ANTIGEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANTIBODY RESPONSE; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG RESPONSE; DRUG SENSITIVITY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HEPATITIS B; HLA TYPING; HUMAN; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; PHARMACOGENETICS; TURKEY (REPUBLIC);

ADULT; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

HEPATITIS B VIRUS;

EID: 79954587053     PISSN: 00062928     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10528-010-9404-6     Document Type: Article

References (45)

1. E Ahishali G Boztas F Akyuz D Ibrisim S Poturoglu B Pinarbasi S Ozdil Z Mungan 2008 Response to hepatitis B vaccination in patients with celiac disease Dig Dis Sci 53 2156 2159 18157638 10.1007/s10620-007-0128-3 1:CAS:528: DC%2BD1cXnvFGgurg%3D
2. SH Ahn KH Han JY Park CK Lee SW Kang CY Chon YS Kim K Park DK Kim YM Moon 2000 Association between hepatitis B virus infection and HLA-DR type in Korea Hepatology 31 1371 1373 10827165 10.1053/jhep.2000.7988 1:CAS:528: DC%2BD3cXkt1CmsLw%3D (Pubitemid 30351301)
3. DY But CL Lai MF Yuen 2008 Natural history of hepatitis related hepatocellular carcinoma World J Gastroenterol 14 1652 1656 18350595 10.3748/wjg.14.1652 (Pubitemid 351493370)
4. S Caillat-Zucman JJ Gimenez F Wambergue G Albouze B Lebkiri C Naret A Moynot P Jungers JF Bach 1998 Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen Kidney Int 53 1626 1630 9607193 10.1046/j.1523-1755.1998.00909.x 1:CAS:528:DyaK1cXjs12lsr4%3D (Pubitemid 28243745)
5. FV Chisari C Ferrari 1995 Hepatitis B virus immunopathogenesis Annu Rev Immunol 13 29 60 7612225 10.1146/annurev.iy.13.040195.000333 1:CAS:528:DyaK2MXltFamtLY%3D
6. SW Cho JY Cheong YS Ju DH Oh YJ Suh KW Lee 2008 Human leukocyte antigen class II association with spontaneous recovery from hepatitis B virus infection in Koreans: analysis at the haplotype level J Korean Med Sci 23 838 844 18955791 10.3346/jkms.2008.23.5.838 1:CAS:528:DC%2BD1cXhsVKmsrnP
7. + T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B Clin Exp Immunol 113 244 251 9717974 10.1046/j.1365-2249.1998.00665.x 1:CAS:528:DyaK1cXls1Kqs7k%3D (Pubitemid 28352843)
8. D Ertem I Gonen C Tanidir M Ugras A Yildiz E Pehlivanoǧlu E Eksioglu-Demiralp 2009 The response to hepatitis B vaccine: does it differ in celiac disease? Eur J Gastroenterol Hepatol 22 787 793 10.1097/MEG. 0b013e32832e9d41
9. European Association for the Study of the Liver 2009 EASL clinical practice guidelines: management of chronic hepatitis B J Hepatol 50 227 242 10.1016/j.jhep.2008.10.001
10. C Ferrari 1995 Hepatitis B virus immunopathogenesis Annu Rev Immunol 13 29 60 7612225 10.1146/annurev.iy.13.040195.000333
11. C Ferrari A Penna A Bertoletti A Valli AD Antoni T Giuberti A Cavalli MA Petit F Fiaccadori 1990 Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection J Immunol 145 3442 3449 2230128 1:CAS:528:DyaK3MXksFer
12. DN Fisman D Agrawal K Leder 2002 The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis Clin Infect Dis 35 1368 1375 12439800 10.1086/344271 (Pubitemid 35448965)
13. Y Futagawa K Waki J Cai 2006 The association of HLA-DR13 with lower graft survival rates in hepatitis B and primary sclerosing cholangitis Caucasian patients receiving a liver transplant Liver Transpl 12 600 604 16555323 10.1002/lt.20678
14. S Gheuens J Fellay DB Goldstein IJ Koralnik 2010 Role of human leukocyte antigen class I alleles in progressive multifocal leukoencephalopathy J Neurovirol 16 41 47 20105104 10.3109/13550280903552438 1:CAS:528: DC%2BC3cXisl2qtL8%3D
15. A Godkin M Davenport AV Hill 2005 Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness Hepatology 41 1383 1390 15915462 10.1002/hep.20716 1:CAS:528: DC%2BD2MXlvVSmsro%3D (Pubitemid 40774886)
16. ST Goldstein F Zhou SC Hadler BP Bell EE Mast HS Margolis 2005 A mathematical model to estimate global hepatitis B disease burden and vaccination impact Int J Epidemiol 34 1329 1339 16249217 10.1093/ije/dyi206 (Pubitemid 41819540)
17. GF Grady VA Lee AM Prince GL Gitnick KA Fawaz GN Vyas MD Levitt JR Senior JT Galambos TE Bynum JW Singleton BF Clowdus K Akdamar RD Aach EI Winkelman GM Schiff T Hersh 1978 Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial J Infect Dis 138 625 638 361899 1:STN:280:DyaE1M%2FkvFehuw%3D%3D (Pubitemid 9058757)
18. LG Guidotti FV Chisari 2001 Noncytolytic control of viral infections by the innate and adaptive immune response Annu Rev Immunol 19 65 91 11244031 10.1146/annurev.immunol.19.1.65 1:CAS:528:DC%2BD3MXivFKgtb0%3D (Pubitemid 32368030)
19. YN Han JL Yang SG Zheng Q Tang W Zhu 2005 Relationship of human leukocyte antigen class II genes with the susceptibility to hepatitis B virus infection and the response to interferon in HBV-infected patients World J Gastroenterol 11 5721 5724 16237774 1:CAS:528:DC%2BD28Xisl2jsg%3D%3D (Pubitemid 41684933)
20. T Höhler G Gerken A Notghi R Lubjuhn H Taheri U Protzer HF Löhr PM Schneider KH Meyer zum Büschenfelde C Rittner 1997 HLA-DRB1*1301 and *1302 protect chronic hepatitis B J Hepatol 26 503 507 9075656 10.1016/S0168-8278(97)80414-X (Pubitemid 27112714)
21. T Höhler E Reuss N Evers E Dietrich C Rittner CM Freitag J Vollmar PM Schneider R Fimmers 2002 Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins Lancet 360 991 995 12383669 10.1016/S0140-6736(02) 11083-X (Pubitemid 35284111)
22. SH Hwang YH Sohn HB Oh CY Hwang SH Lee ES Shin KJ Lee 2007 Human leukocyte antigen alleles and haplotypes associated with chronicity of hepatitis B virus infection in Koreans Arch Pathol Lab Med 131 117 121 17227111 (Pubitemid 46174146)
23. YG Jiang YM Wang TH Liu J Liu 2003 Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B World J Gastroenterol 9 2221 2225 14562382 1:CAS:528:DC%2BD3sXpsVOjtrY%3D (Pubitemid 37321449)
24. MA Karan NE Tascioglu AO Ozturk S Palanduz M Carin 2002 The role of HLA antigens in chronic hepatitis B virus infection J Pak Med Assoc 52 253 256 12503591 1:STN:280:DC%2BD38jktVSkug%3D%3D
25. C Liu B Cheng 2007 Association of polymorphisms of human leucocyte antigen-DQA1 and DQB1 alleles with chronic hepatitis B virus infection, liver cirrhosis and hepatocellular carcinoma in Chinese Int J Immunogenet 34 373 378 17845309 10.1111/j.1744-313X.2007.00702.x 1:CAS:528:DC%2BD2sXhtFeksbzL (Pubitemid 47383396)
26. AS Lok BJ McMahon 2001 Chronic hepatitis B Hepatology 34 1225 1241 11732013 10.1053/jhep.2001.29401 1:STN:280:DC%2BD3MnosV2qtw%3D%3D (Pubitemid 33096596)
27. WC Maddrey 2001 Hepatitis B: an important public health issue Clin Lab 47 51 55 11214223 1:STN:280:DC%2BD3M7ls1SltQ%3D%3D (Pubitemid 32118099)
28. A McDermott J Zuckerman C Sabin S Marsh J Madrigal 1997 Contribution of human leukocyte antigens to antibody response to hepatitis B vaccination Tissue Antigens 50 8 14 9243749 10.1111/j.1399-0039.1997.tb02827.x 1:CAS:528: DyaK2sXltVekurw%3D (Pubitemid 27273706)
29. A McMichael P Klenerman 2002 HIV/AIDS: HLA leaves its footprints on HIV Science 296 1410 1411 12029119 10.1126/science.1072492 1:CAS:528: DC%2BD38XktFamu74%3D (Pubitemid 34553075)
30. J McNicholl 1998 Host genes and infectious diseases Emerg Infect Dis 4 423 426 9716963 10.3201/eid0403.980322 1:STN:280:DyaK1czot1Kqsw%3D%3D (Pubitemid 28387425)
31. XQ Meng HG Chen YL Ma KZ Liu 2003 Influence of HLA class II molecules on the outcome of hepatitis B virus infection in population of Zhejiang Province in China Hepatobiliary Pancreat Dis Int 2 230 233 14599975 1:CAS:528: DC%2BD3sXksFeisrk%3D
32. D Moradpour JR Wands 1995 Understanding hepatitis B virus infection New Engl J Med 332 1092 1093 7898530 10.1056/NEJM199504203321610 1:STN:280:DyaK2M3gs1eguw%3D%3D
33. A Ramezani MR Hasanjani Roshan E Kalantar A Eslamifar M Banifazl J Taeb A Aghakhani L Gachkar AA Velayati 2008 Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection J Gastroenterol Hepatol 23 1716 1721 18761557 10.1111/j.1440-1746.2008.05482.x
34. GM Schreuder CK Hurley SG Marsh M Lau M Fernandez-Vina HJ Noreen M Setterholm M Maiers 2005 The HLA dictionary 2004: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens Int J Immunogenet 32 19 69 15686589 10.1111/j.1744-313X.2005.00497.x 1:CAS:528:DC%2BD2MXhsFOjtr0%3D (Pubitemid 40222589)
35. K Scott ASFL Fung 2004 Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 40 790 792
36. R Singh R Kaul A Kaul K Khan 2007 A comparative review of HLA associations with hepatitis B and C viral infections across global populations World J Gastroenterol 13 1770 1787 17465466 1:CAS:528:DC%2BD2sXmtV2lu7k%3D (Pubitemid 46706009)
37. AT Tan S Koh V Goh A Bertoletti 2008 Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective J Gastroenterol Hepatol 23 833 843 18565018 10.1111/j.1440-1746.2008.05385.x 1:CAS:528:DC%2BD1cXptFyls70%3D (Pubitemid 351806581)
38. CL Thio M Carrington D Marti SJ O'Brien D Vlahov KE Nelson JA Astemborski DL Thomas 1999 Class II of HLA alleles and hepatitis B virus persistence in African Americans J Infect Dis 179 1004 1006 10068598 10.1086/314684 1:STN:280:DyaK1M7mvFWqsQ%3D%3D (Pubitemid 29159348)
39. CL Thio DL Thomas P Karacki 2003 Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection J Virol 77 12083 12087 14581545 10.1128/JVI.77.22.12083-12087.2003 1:CAS:528:DC%2BD3sXovVantr0%3D (Pubitemid 37345173)
40. MR Thursz D Kwiatkowski CE Allsopp BM Greenwood HC Thomas AV Hill 1995 Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia New Engl J Med 332 1065 1069 7898524 10.1056/NEJM199504203321604 1:STN:280:DyaK2M3gs1egsQ%3D%3D
41. TS Uinuk-Ool N Takezaki OA Derbeneva NV Volodko RI Sukernik 2004 Variation of HLA class II genes in the Nganasan and Ket, two aboriginal Siberian populations Eur J Immunogenet 31 43 51 15009181 10.1111/j.1365-2370.2004.00443. x 1:CAS:528:DC%2BD2cXjtlGjtL0%3D (Pubitemid 38396719)
42. M Varla-Laftnerioti M Papanicolaou M Spyropoulou H Vallindra P Tsiroyianni N Tassopoulos H Kapasouri C Stavropoulos-Giokas 1990 HLA-associated non-responsiveness to hepatitis B vaccine Tissue Antigens 35 60 63 10.1111/j.1399-0039.1990.tb01757.x
43. YF Wu LY Wang TD Lee HH Lin CT Hu ML Cheng SY Lo 2004 HLA phenotypes and outcomes of hepatitis B virus infection in Taiwan J Med Virol 72 17 25 14635006 10.1002/jmv.10557 (Pubitemid 37484738)
44. G Yang J Liu S Han H Xie R Du Y Yan D Xu D Fan 2007 Association between hepatitis B virus infection and HLA-DRB1 genotyping in Shaanxi Han patients in northwestern China Tissue Antigens 69 170 175 17257320 10.1111/j.1399-0039.2006. 00744.x 1:CAS:528:DC%2BD2sXjsVejtb0%3D (Pubitemid 46174872)
45. AR Zanetti P Van Damme D Shouval 2008 The global impact of vaccination against hepatitis B: a historical overview Vaccine 26 6266 6273 18848855 10.1016/j.vaccine.2008.09.056